UK
UK
Apr-17
Cardiovascular Pharmacoepidemiology Rheumatology
Read moreApr-17
Cardiovascular Pharmacoepidemiology
Read moreApr-17
Database Demographics General Analysis
Read moreMar-17
Endocrinology Gastroenterology Oncology
Read moreMar-17
Mar-17
Cardiovascular Virology and Immunisations
Read moreMar-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMar-17
General Analysis Mental Health
Read moreMar-17
Mar-17
Endocrinology Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Apr-17 | Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study | Read more | |
| Apr-17 | Survival following a diagnosis of heart failure in primary care | Read more | |
| Apr-17 | Use of azithromycin and risk of ventricular arrhythmia | Read more | |
| Apr-17 | Weighted multiple imputation of ethnicity data that are missing not at random in primary care databases | Read more | |
| Mar-17 | A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes | Read more | |
| Mar-17 | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin | Read more | |
| Mar-17 | A meta-analysis of stroke risk following herpes zoster infection | Read more | |
| Mar-17 | Adding a Glucagon like peptide‐1 analogue (GLP‐1RA) has a favourable effect on mortality and cardiovascular events among insulin‐treated patients with Type 2 diabetes: a large retrospective UK cohort study | Read more | |
| Mar-17 | Death following partner bereavement: A self-controlled case series analysis | Read more | |
| Mar-17 | Documented hypoglycaemic events in patients with Type 2 diabetes in primary care and risk of fractures: a population‐based, open‐cohort study | Read more | |
| Mar-17 | Effectiveness of liraglutide and lixisenatide in the treatment of Type 2 diabetes: real world evidence from The Health Improvement Network (THIN) database in the United Kingdom (UK) | Read more | |
| Mar-17 | Glucagon‐like peptide 1 agonists and death from any cause in primary care setting | Read more |
